Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Letter to Editor
18 (
2
); 85-85
doi:
10.4103/0971-4065.42349

Effect of taurine and acetylcysteine in attenuating microalbuminuria in type 2 diabetes

Diabetes Research Centre (WHO Collaborating Centre for Research, Education and Training in Diabetes), Chennai, Tamil Nadu, India

Address for correspondence: Dr. Vijay Viswanathan, Diabetes Research Centre (WHO Collaborating Centre for Research, Education and Training in Diabetes), No. 4, Main Road, Royapuram, Chennai - 600 013, Tamil Nadu, India. E-mail: dr_vijay@vsnl.com

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Disclaimer:
This article was originally published by Medknow Publications and was migrated to Scientific Scholar after the change of Publisher.

Sir,

It is shown that glomerular damage in diabetes can be prevented or at least attenuated by supplementation with taurine and N-acetylcysteine.1 Diet supplemented with taurine was found to reduce the morphological damage in experimental models with diabetes. Hence, this study was conducted to determine the benefits of treatment with combination of taurine (500 mg) and acetylcysteine (150 mg) (Nefrosave™, Fourrts (India) Laboratories Pvt. Limited) in reversal of microalbuminuria in type 2 diabetic subjects and to evaluate its potential in augmenting the renoprotective action of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB).

The institutional ethics committee approved the study, and written informed consent was obtained from patients. Among the 41 well-controlled type 2 diabetic patients with microalbuminuria, 31 patients were given a combination of taurine and N-acetylcysteine along with an ACEI/ARB (treatment group) and 10 patients were treated with an ACEI/ARB alone (control group). Male:female ratio was 27:14. Both the treatment arms received similar doses of 5 mg of ACEI and 50 mg of ARB. Fasting plasma glucose, glycosylated hemoglobin triglycerides, cholesterol, urinary albumin/creatinine ratio (UACR), and serum transforming growth factor (sTGF-b1) were determined at baseline and at the end of 3 months of treatment period. The UACR was determined by immunoturbidimetry and sTGF-b1 was analyzed by sandwich enzyme linked immunosorbent assay.

There was no significant difference between the treatment group and the control group with respect to baseline parameters like age (treatment group: 59 ± 7, control group: 60 ± 12 years), duration of diabetes (treatment group: 14 ± 7, control group: 17 ± 5 years), and weight (treatment group: 70 ± 14, control group: 69 ± 11 kg). At follow-up, significant reduction in diastolic blood pressure (DBP) (baseline: 82 ± 08 vs. follow-up: 78 ± 05 mmHg, P = 0.021), UACR (baseline: 85 ± 59 vs. follow-up: 45 ± 25 mg/mg creatinine, P = 0.001), and sTGF-b1 (baseline: 18.3 ± 12.4 vs. follow-up: 13.2 ± 9.9, P = 0.002) were seen in the treatment group. No such significant changes were noted in the control group [DBP - baseline: 79 ± 7 vs. follow-up: 79 ± 6 mmHg, P = 0.2; UACR - baseline: 61 ± 29 vs. follow-up: 92 ± 52 mg/mg creatinine, P = 0.2; and sTGF-β1 - baseline: 20 ± 4.2 vs. follow-up: 19.7 ± 8.1, P = 0.6)]. Along with the above parameters, glomerular filtration rate (GFR) was also estimated using Cockroft Gault Equation.2 However, it was found that there was some increase in the GFR in the control group (baseline: 81.9 ± 23.9, follow-up: 95.5 ± 26.3; P = 0.2) compared with the treatment group (baseline: 84.0 ± 26.2, follow-up: 88.1 ± 30.3; P = 0.6) but the increase was not statistically significant.

This prospective study showed that taurine in combination with N-acetylcysteine was useful in attenuating UACR and sTGF-β1 levels in microalbuminuric type 2 diabetic patients. The benefits of taurine therapy on kidney function and blood pressure are noteworthy and may be useful in preventing the deterioration of microalbuminuria. The limitation of the study is its small sample size. A larger cohort with longer follow-up is needed to validate the findings of this study.

References

  1. , , , , , . Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes. 2003;52:499-505.
    [Google Scholar]
  2. , , . Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
    [Google Scholar]

Fulltext Views
142

PDF downloads
72
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections